Citations 1
474 Phase 1 study of SEA-TGT, a human, nonfucosylated anti-TIGIT monoclonal antibody with enhanced immune-effector function, in patients with advanced malignancies (SGNTGT-001, trial in progress)
Garralda, Elena , Oberoi, H.K., Herrera, Alex F. , Forero‐Torres, Andres , Ansell, Stephen, Davar, Diwakar , Ribrag, Vincent , Sarkozy, Clémentine , Mehta, Amitkumar , Curigliano, Giuseppe , Belli, Carmen , Zain, Jasmine , Sanborn, Rachel E , Dumbrava, Ecaterina E.
Regular and Young Investigator Award Abstracts | November 9, 2021 | Volume: No volume available | Issue: No issue available | Pages: A503-A503
